Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog (LHRHa) during chemotherapy as a strategy to reduce ovarian failure in early breast cancer patients

This article has no abstract
Epistemonikos ID: f7da22812015527662ad8f8fdef3c5df0bccafdb
First added on: Feb 07, 2025